Weekly News Round-up – 5/3/21

In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...

10 hours ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,Biology

Weekly News Round-up – 5/3/21

In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...

10 hours ago

Weekly News Round-up – 19/2/21

PFIZER AND MODERNA VACCINES LESS POTENT AGAINST AGGRESSIVE COVID VARIANTS – Further evidence has arisen suggesting Pfizer and its partner BioNTech must update their current vaccines to defeat newer variants of COVID-19. In a letter published in the New England...

2 weeks ago
R&D,Bioprocess,Weekly Roundups,Biology

Weekly News Round-up – 19/2/21

PFIZER AND MODERNA VACCINES LESS POTENT AGAINST AGGRESSIVE COVID VARIANTS – Further evidence has arisen suggesting Pfizer and its partner BioNTech must update their current vaccines to defeat newer variants of COVID-19. In a letter published in the New England...

2 weeks ago

Weekly News Round-up – 29/1/21

In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...

1 month ago
R&D,Bioprocess,Weekly Roundups,Biology,News

Weekly News Round-up – 29/1/21

In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...

1 month ago

Weekly News Round-up – 22/1/21

In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...

1 month ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 22/1/21

In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...

1 month ago

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 months ago

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

2 months ago

The Future of CMC: An Interview with Jean-Pierre Metabanzoulou

The need to ensure patient safety and drug efficacy in pharmaceuticals is only increasing. With the sudden disruption caused by the COVID-19 pandemic, the Chemistry and Manufacturing Controls (CMC) process has been thrown into the spotlight as critical to drug...

3 months ago
Biomanufacturing,CMC,Regulatory Affairs,News

The Future of CMC: An Interview with Jean-Pierre Metabanzoulou

The need to ensure patient safety and drug efficacy in pharmaceuticals is only increasing. With the sudden disruption caused by the COVID-19 pandemic, the Chemistry and Manufacturing Controls (CMC) process has been thrown into the spotlight as critical to drug...

3 months ago

Better CMC Organisation in Small Pharma Drug Development

Chemistry, Manufacturing and Controls (CMC) is a vital part of the drug development process. A CMC strategy gives companies a template for bringing a drug through the early clinical stages all the way to commercial manufacturing.  The CMC process has...

5 months ago
Bioprocess,Biomanufacturing,CMC,Regulatory Affairs,News

Better CMC Organisation in Small Pharma Drug Development

Chemistry, Manufacturing and Controls (CMC) is a vital part of the drug development process. A CMC strategy gives companies a template for bringing a drug through the early clinical stages all the way to commercial manufacturing.  The CMC process has...

5 months ago

Solving Regulatory Issues in Cell and Gene Therapies

Cell and Gene Therapies (CGTs), experimental technologies to treat or cure diseases using the body’s cells, have been on the ascendant for some time now. As promising as they are, CGTs have consistently moved forward faster than regulatory agencies can...

5 months ago
Bioprocess,CGT,Biomanufacturing,Regulatory Affairs,News

Solving Regulatory Issues in Cell and Gene Therapies

Cell and Gene Therapies (CGTs), experimental technologies to treat or cure diseases using the body’s cells, have been on the ascendant for some time now. As promising as they are, CGTs have consistently moved forward faster than regulatory agencies can...

5 months ago

Weekly News Round-up – 11/9/20

In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...

6 months ago
Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 11/9/20

In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...

6 months ago